Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics: ethical problems and solutions.

Alasdair Breckenridge1, Klaus Lindpaintner, Peter Lipton

  • 1UK Medicines and Healthcare products Regulatory Agency.

Nature Reviews. Genetics
|September 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The power of webinars: expanding diverse female representation and role models in surgery.

BMC medical education·2026
Same author

Acquired cystic fibrosis transmembrane conductance regulator dysfunction.

Pflugers Archiv : European journal of physiology·2025
Same author

ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.

Journal for immunotherapy of cancer·2025
Same author

Biomedical Innovation and Equitable Access.

JAMA·2025
Same author

Malignant pleural mesothelioma associated with recurrent pneumothorax.

Breathe (Sheffield, England)·2025
Same author

The Key Features of a Genetic Nondiscrimination Policy: A Delphi Consensus Statement.

JAMA network open·2024
Same journal

Genetic origins and constraints of evolutionary innovation.

Nature reviews. Genetics·2026
Same journal

Single-cell four-omics with CHARM.

Nature reviews. Genetics·2026
Same journal

Molecular integration of seasonal temperature signals in flowering time control.

Nature reviews. Genetics·2026
Same journal

RBPscan measures protein-RNA interactions in living cells.

Nature reviews. Genetics·2026
Same journal

Revisiting retinal and macular degeneration in the genomics era.

Nature reviews. Genetics·2026
Same journal

How evolution builds three morphs from one genome.

Nature reviews. Genetics·2026
See all related articles

Pharmacogenetics (PGx) will revolutionize disease treatment, but ethical considerations surrounding its integration into drug discovery and clinical use require immediate attention and proactive solutions.

Area of Science:

  • Pharmacogenetics
  • Bioethics
  • Drug Discovery and Development

Background:

  • Pharmacogenetics (PGx) is poised to significantly alter disease treatment approaches.
  • Growing recognition of PGx's impact spans regulators, industry, academia, clinicians, and the public.
  • Ethical implications of integrating PGx testing into the drug lifecycle are increasingly under scrutiny.

Purpose of the Study:

  • To explore the ethical issues associated with pharmacogenetics testing.
  • To present diverse viewpoints on the ethical challenges of PGx implementation.
  • To emphasize the need for timely development of ethical frameworks and solutions.

Main Methods:

  • Analysis of diverse perspectives from stakeholders including regulators, drug companies, scientists, bioethicists, and clinicians.
Keywords:
Genetics and Reproduction

Related Experiment Videos

  • Discussion of ethical considerations in pharmacogenetic testing across drug discovery, prescription, and use.

    • Main Results:

    • Significant thought has been given to the ethical issues of pharmacogenetics by various stakeholders.
    • Diverse viewpoints highlight the complexity and multifaceted nature of PGx ethical challenges.
    • Current discussions underscore the urgency for formulating and implementing ethical solutions.

    Conclusions:

    • The integration of pharmacogenetics into healthcare necessitates a comprehensive ethical strategy.
    • Proactive engagement and collaboration among all stakeholders are crucial for addressing PGx ethical concerns.
    • Immediate action is required to develop and implement ethical guidelines for pharmacogenetic applications.